524572

Pharmaids Pharmaceuticals Share PricePharmaids Pharmaceuticals

₹39.00
-0.2 (-0.51%)
As on 30 September, 2023 | 06:12 BSE: 524572 NSE: PHARMAIDISIN: INE117D01018

Pharmaids Pharmaceuticals Performance

Day Range

  • Low
  • High
39.00

52 Week Range

  • Low
  • High
39.00
  • Open Price
  • Previous Close
  • Volume

Start SIP in Pharmaids Pharmaceuticals

Start SIP

Pharmaids Pharmaceuticals Share Price

  • Over 1 Month -2.5%
  • Over 3 Month -7.3%
  • Over 6 Month 78.82%
  • Over 1 Year 189.1%

Pharmaids Pharmaceuticals Key Statistics

Pharmaids Pharmaceuticals Investment Rating

  • Master Rating:
  • Pharmaids Pharms. has an operating revenue of Rs. 0.30 Cr. on a trailing 12-month basis. Pre-tax margin of 0% needs improvement, ROE of -33% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 62% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 3 which is a POOR score indicating inconsistency in earnings, a RS Rating of 83 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 111 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has some relative strength and buyer demand but we want to see further fundamental performance to qualify as a growth stock.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Pharmaids Pharmaceuticals Financials
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 000000
Operating Expenses Qtr Cr 291100
Operating Profit Qtr Cr -2-9-1-100
Depreciation Qtr Cr 000000
Interest Qtr Cr 000000
Tax Qtr Cr 0-20000
Net Profit Qtr Cr -1-6-1-100
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 04
Operating Expenses Annual Cr 104
Operating Profit Annual in Cr -100
Depreciation Cr 00
Interest Annual Cr 00
Tax Annual Cr -20
Net Profit Annual Cr -80
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr -40
Cash from Investing Activity Annual Cr -50
Cash from Financing Annual Activity Cr 21
Net Cash Flow Annual Cr 120
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 229
Fixed Assets Annual Cr 20
Total Non Current Assets Annual Cr 78
Total Current Assets Annual Cr 173
Total Assets Annual Cr 2511
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 108
ROE Annual % -342
ROCE Annual % -442
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 04
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 0000
Operating Expenses Qtr Cr 2910
Operating Profit Qtr Cr -2-9-10
Depreciation Qtr Cr 0000
Interest Qtr Cr 0000
Tax Qtr Cr 0-200
Net Profit Qtr Cr -1-6-10
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 04
Operating Expenses Annual Cr 104
Operating Profit Annual in Cr -100
Depreciation Cr 00
Interest Annual Cr 00
Tax Annual Cr -20
Net Profit Annual Cr -80
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr -40
Cash from Investing Activity Annual Cr -50
Cash from Financing Annual Activity Cr 21
Net Cash Flow Annual Cr 120
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 229
Fixed Assets Annual Cr 20
Total Non Current Assets Annual Cr 78
Total Current Assets Annual Cr 183
Total Assets Annual Cr 2511
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 108
ROE Annual % -342
ROCE Annual % -442
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 04

Pharmaids Pharmaceuticals Technicals

EMA & SMA

Current Price
₹39.00
-0.2 (-0.51%)
  • Bullish Moving Average
  • ___
  • 14
  • Bearish Moving Average
  • ___
  • 2
  • 20 Day
  • ₹38.43
  • 50 Day
  • ₹37.3
  • 100 Day
  • ₹33.62
  • 200 Day
  • ₹27.71
  • 20 Day
  • ₹38.18
  • 50 Day
  • ₹38.41
  • 100 Day
  • ₹34.41
  • 200 Day
  • ₹24.24

Pharmaids Pharmaceuticals Resistance and Support

PIVOT
₹38.88
Resistance
First Resistance ₹39.33
Second Resistance ₹39.66
Third Resistance ₹40.11
RSI 53.44
MFI 54.68
MACD Single Line 0.23
MACD 0.45
Support
First Resistance ₹38.55
Second Resistance ₹38.1
Third Resistance ₹37.77

Pharmaids Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 2,675 267,500 100
Week 13,043 1,304,300 100
1 Month 9,808 980,786 100
6 Month 8,261 826,132 100

Pharmaids Pharmaceuticals Result Highlights

Pharmaids Pharmaceuticals Synopsis

BSE-Medical-Diversified

Pharmaids Pharma belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 21.44 Cr. for the Year ended 31/03/2023. Pharmaids Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 01/03/1989 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L52520KA1989PLC173979 and registration number is 173979.
Market Cap 84
Sales
Shares in Float 1.93
No of funds
Yield
Book Value 3.73
U/D Vol ratio 0.7
LTDebt / Equity
Alpha 0.79
Beta 0.63

Pharmaids Pharmaceuticals

Owner NameJun-23Mar-23Jan-23Dec-22
Promoters 9.94%9.95%16.45%16.54%
Individual Investors 81.28%81.71%69.87%69.78%
Others 8.78%8.34%13.68%13.68%

Pharmaids Pharmaceuticals Management

Name Designation
Mr. Venu Madhava Kaparthy Executive Director
Ms. Mini Manikantan Executive Director
Mr. Venkata Rao Sadhanala Non Exe.Non Ind.Director
Mr. Mopperthy Sudheer Independent Director
Mr. Methuku Nagesh Independent Director
Mr. P N Vijay Independent Director

Pharmaids Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Pharmaids Pharmaceuticals Corporate Action

Date Purpose Remarks
2023-08-04 Quarterly Results
2023-05-29 Audited Results
2023-02-13 Quarterly Results
2023-01-17 Others
2022-12-06 Others Rs.0.00 to consider Preferential issue of 84,00,000 equity shares of Rs. 10/- each in accordance with applicable provisions and subject to necessary approvals..
  • Company Name
  • CMP
  • Chg(%)
  • Company Name
  • CMP
  • Chg(%)

Pharmaids Pharmaceuticals FAQs

What is Share Price of Pharmaids Pharmaceuticals ?

Pharmaids Pharmaceuticals share price is ₹39 As on 30 September, 2023 | 05:58

What is the Market Cap of Pharmaids Pharmaceuticals ?

The Market Cap of Pharmaids Pharmaceuticals is ₹83.8 Cr As on 30 September, 2023 | 05:58

What is the P/E ratio of Pharmaids Pharmaceuticals ?

The P/E ratio of Pharmaids Pharmaceuticals is -9.6 As on 30 September, 2023 | 05:58

What is the PB ratio of Pharmaids Pharmaceuticals ?

The PB ratio of Pharmaids Pharmaceuticals is 3.7 As on 30 September, 2023 | 05:58

Q2FY23